Pancreatic Cancer Market Trends

Growth Drivers

• Increasing R&D activity and investments: The growing frequency and count of financially funded research projects are propelling progress in the pancreatic cancer market. These efforts to identify novel agents and combined therapies to treat both metastatic and locally advanced PCs are expanding the pipeline of this sector. For instance, in September 2024, the City of Hope received a private fund of USD 150.0 million to provide economic support to the leading research cohorts across the U.S. with promising advancements and discoveries. Similarly, in October 2024, the University of Michigan Health earned a grant of USD 50.0 million to construct the Rogel and Blondy Center, revolutionizing the diagnosis and treatment of PC.
• Improvements in therapy kinetics and detection accuracy: Backed by technologically advanced laboratory and clinical tools, the existing portfolio of the market is improving. The introduction of AI and single-cell analysis in anti-cancer drug discovery is enhancing the treatment prognosis and quality of life of patients. Emerging platforms such as mRNA therapeutics and oncolytic viruses are also accelerating the sector’s worldwide penetration. On this note, in October 2024, Oncolytics Biotech shared its plans to explore the potential of pelareorep in pancreatic cancer by conducting a GOBLET study. This trial is funded by The Pancreatic Cancer Action Network (PanCAN).

Challenges

• Growing concerns about adverse reactions and long-term efficacy: The side effects of harsh treatment methods, such as chemotherapy, include pain, dizziness, fever, vomiting, and frequent bowel movements. Additionally, the side effects of radiation therapy cause diarrhea, shortness of breath, change in taste, and urinary & bladder problems. All these factors accumulatively create hesitation among patients about adopting solutions from the market. However, rigorous R&D and large-scale evaluation have the potential to establish a strong safety profile for new therapies, helping companies gain maximum consumer adherence and regulatory compliance.